Literature DB >> 17056007

Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression.

Xiuwu Zhang1, Tong H Lee, Xueying Xiong, Qiang Chen, Colin Davidson, William C Wetsel, Everett H Ellinwood.   

Abstract

The present study investigated whether GABA(A) receptor alpha2 subunit and GAD(67) are involved in chronic high dose methamphetamine (METH)-induced sensitization and neurotoxicity. The METH sensitization was established in rats by 7-day pump infusion plus daily injection (25mg/kg/day) and a subsequent 28-day withdrawal period. Behavioral sensitization was assessed by behavioral ratings after challenge with METH (0.5mg/kg). The neurotoxicity was evaluated by the expression of glial fibrillary acidic protein (GFAP). Western blot assay showed that METH sensitization decreases GABA(A) alpha2 subunit and GAD(67) protein levels in the nucleus accumbens (NAc) core and shell, and conversely, these proteins were increased in the caudate. An upregulation of GFAP expression was observed in the caudate, but not in the NAc core and shell. These data suggest that inhibition of GABA transmission in the NAc is related to METH behavioral sensitization, whereas activation of GABA transmission in the caudate is associated with METH-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056007     DOI: 10.1016/j.bbrc.2006.10.046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.322


  22 in total

1.  Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.

Authors:  Miles G Cunningham; Ryan P O'Connor; Sydney E Wong
Journal:  J Vis Exp       Date:  2008-03-17       Impact factor: 1.355

2.  Effect of Methamphetamine Exposure on Expression of Calcium Binding Proteins in Rat Frontal Cortex and Hippocampus.

Authors:  Siriluk Veerasakul; Samur Thanoi; Gavin P Reynolds; Sutisa Nudmamud-Thanoi
Journal:  Neurotox Res       Date:  2016-05-14       Impact factor: 3.911

3.  Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice.

Authors:  Chuan-Ching Lai; Li-Jen Lee; Hsiang-Shu Yin
Journal:  Neurochem Res       Date:  2014-08-19       Impact factor: 3.996

4.  Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression.

Authors:  Tong Ni; Li Zhu; Shuai Wang; Weili Zhu; Yanxue Xue; Yingjie Zhu; Dongliang Ma; Hongyan Wang; Fanglin Guan; Teng Chen
Journal:  Mol Psychiatry       Date:  2022-06-22       Impact factor: 15.992

5.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

6.  Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.

Authors:  Katherine J Smith; Tracy R Butler; Rachel L Self; Brittany B Braden; Mark A Prendergast
Journal:  Brain Res       Date:  2007-10-18       Impact factor: 3.252

7.  Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

Authors:  Jennifer Treweek; Sunmee Wee; George F Koob; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

8.  Associations of glutamate decarboxylase genes with initial sensitivity and age-at-onset of alcohol dependence in the Irish Affected Sib Pair Study of Alcohol Dependence.

Authors:  Po-Hsiu Kuo; Gursharan Kalsi; Carol A Prescott; Colin A Hodgkinson; David Goldman; Jeffry Alexander; Edwin J van den Oord; Xiangning Chen; Patrick F Sullivan; Diana G Patterson; Dermot Walsh; Kenneth S Kendler; Brien P Riley
Journal:  Drug Alcohol Depend       Date:  2008-12-25       Impact factor: 4.492

9.  Rocuronium for control of muscle spasms in a tetanus patient with chronic methamphetamine use disorder.

Authors:  Clare Angeli Guinto Enriquez; Joshua Emmanuel Edillon Abejero; Philip A Ramiro; Carissa Paz Dioquino Maligaso
Journal:  BMJ Case Rep       Date:  2018-04-10

10.  Rocuronium as Neuromuscular Blockade in Tetanus Patients With Methamphetamine Use Disorder: A Case Report.

Authors:  Robert Joseph Cruz Sarmiento; Clare Angeli G Enriquez; Francis Gerwin Jalipa; Bernadeth Lyn Piamonte; Jose Danilo Diestro; Carissa Paz Dioquino; Alberto Goffi; Roland Dominic G Jamora
Journal:  Neurohospitalist       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.